PeerVoice Internal Medicine Audio
By PeerVoice
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by PeerVoice
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 39
Reviews: 0
Episodes: 303
Description
PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Internal Medicine that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
| Episode | Date |
|---|---|
|
Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
|
Jun 05, 2026 |
|
David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real World
|
Jun 05, 2026 |
|
Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer
|
May 26, 2026 |
|
Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke Prevention
|
May 26, 2026 |
|
Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology Masterclass
|
May 18, 2026 |
|
Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care Professional
|
May 18, 2026 |
|
Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
|
May 18, 2026 |
|
Jonathan Barratt, PhD, FRCP - From Mechanisms to Action: Exploring the Therapeutic Potential of Complement Inhibition in IgA Nephropathy
|
Apr 29, 2026 |
|
Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can
|
Apr 29, 2026 |
|
Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 Diabetes
|
Apr 29, 2026 |
|
Austin Kulasekararaj, MD, MRCP, FRCPath - From Life-Threatening to Life-Optimised: The Evolving Management of Paroxysmal Nocturnal Haemoglobinuria Across the Complement Cascade
|
Mar 25, 2026 |
|
Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?
|
Mar 06, 2026 |
|
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
|
Feb 25, 2026 |
|
David Kavanagh, MBChB, PhD, FRCP - A Clinically Considered Real-World Case Series: Practice Essentials From Biopsy To Diagnosis in Immune-Mediated Glomerular Diseases
|
Feb 25, 2026 |
|
Yohei Doi, MD, PhD - Know the Risk, Act on Evidence: Strategic Interventions in COVID-19 Care of High-Risk Patients
|
Feb 04, 2026 |
|
Ira Goldberg, MD - Mastering the Fundamentals of Care for Chylomicronemia: Following the Patient Care Pathway From Differential Diagnosis to Modern Management
|
Jan 14, 2026 |
|
Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?
|
Jan 07, 2026 |
|
Ira Goldberg, MD - The Expanding Treatment Landscape for Familial Chylomicronemia Syndrome: Exploring New Options and Opportunities
|
Dec 31, 2025 |
|
Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy
|
Dec 31, 2025 |
|
Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH
|
Dec 23, 2025 |
|
Francesco Passamonti, MD - Myelofibrosis Under the Microscope: Exploring p53 Dysregulation as a Potential Therapeutic Target
|
Dec 17, 2025 |
|
Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies
|
Dec 17, 2025 |
|
Jonathan Barratt, PhD, FRCP - 2025 Congress Highlights From Houston, Texas: Breaking Down the Data Driving Therapeutic Developments in IgA Nephropathy
|
Dec 16, 2025 |
|
Carla M. Nester, MD, MSA, FASN - 2025 Congress Highlights From Houston, Texas: Translating C3G and IC-MPGN Trials to Treatment in an Era of Complement Inhibition
|
Dec 16, 2025 |
|
Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?
|
Dec 16, 2025 |
|
Jonathan Barratt, PhD, FRCP - 2025 Congress Highlights From Houston, Texas: A Fresh Look at the Data Driving Targeted Therapeutic Developments in IgA Nephropathy
|
Dec 05, 2025 |
|
James F. Howard Jr, MD - Direct From San Francisco: Emerging Data and Expert Perspectives on Targeted Therapies for gMG
|
Nov 21, 2025 |
|
Nancy Carteron, MD, FACR - Congress Insights Direct From Chicago: The Need-to-Knows on B Cell–Targeting in Sjögren’s Disease
|
Nov 21, 2025 |
|
Mike Sharma, MD, MSc, FRCPC - Challenging the Status Quo in Secondary Stroke Prevention: Current Perspectives on the Potential of Factor XIa Inhibition
|
Nov 21, 2025 |
|
David Alain Wohl, MD - Inpatient Management of SARS-CoV-2 Infection: Applying Learnings From Real World Evidence to Real World Practice
|
Nov 21, 2025 |
|
Francesco Cappelli, MD, PhD - Meaningful Data From Madrid: Expanding Our Understanding of Phase 3s and OLEs in ATTR-CM
|
Nov 19, 2025 |
|
Sanjay Popat, FRCP, PhD - Don’t Forget About HER2: Clinical Insights and Novel Therapies for HER2-Mutant NSCLC From ESMO 2025
|
Nov 08, 2025 |
|
Emer Joyce, MB BCh BAO, PhD - Staying Ahead of the Curve in ATTR-CM: Adapting and Advancing Our Approach to Decision-Making as the Treatment Landscape Evolves
|
Nov 08, 2025 |
|
Suxia Wang, MD - Expert Perspective on the Diagnostic Pathways for Glomerular Diseases
|
Oct 30, 2025 |
|
Patrick Vermersch, MD, PhD - Stripped Back: CNS Inflammation and the Potential for Meaningful Therapeutic Progress in Non-Relapsing Forms of Multiple Sclerosis
|
Oct 30, 2025 |
|
Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC
|
Oct 30, 2025 |
|
Nadia Harbeck, MD, PhD - Antibody-Drug Conjugates in Breast Cancer: Keeping Abreast of the Latest Data As They Emerge From ESMO
|
Oct 30, 2025 |
|
Alice M. Turner, MBChB, PhD - Cross-Talk Between Lung and Liver in Alpha-1 Antitrypsin Deficiency: A Call for Integrated Care
|
Oct 30, 2025 |
|
Jonathan Barratt, PhD, FRCP - Preserve and Prevent: Expert Perspectives on Optimizing Outcomes in Patients With IgAN
|
Oct 16, 2025 |
|
Solange Peters, MD, PhD - Pioneering Precision: A Real-World Roadmap to Optimal Outcomes in NTRK Fusion-Positive and HER2-Mutant Advanced NSCLC
|
Oct 03, 2025 |
|
Alicia K. Morgans, MD, MPH - Clinical Conversations in Castration-Resistant Prostate Cancer: Best Practices in Discussing Testing and Treatment With Patients
|
Oct 01, 2025 |
|
Jonathan Barratt, PhD, FRCP - The Gut–Kidney Axis and Beyond in IgA Nephropathy: A New Frontier in Precision Therapy
|
Sep 30, 2025 |
|
Amber S. Podoll, MD, FASN - Stepping Up Kidney Protection in Patients With Lupus Nephritis: When and How?
|
Sep 30, 2025 |
|
Eva Diehl - Wiesenecker, MD - Rare Causes of Abdominal Pain: Differential Diagnosis of Uncommon but Diagnosable Causes in the Emergency Room
|
Sep 11, 2025 |
|
Alberto Ortiz, MD, PhD - Rare, Complex, and Life-Threatening: Recognizing and Responding to Atypical Hemolytic Uremic Syndrome
|
Sep 05, 2025 |
|
Richard A. Lewis, MD - Navigating the Evolving CIDP Treatment Landscape: Expert Perspectives on the Therapeutic Potential of Complement Inhibition
|
Sep 05, 2025 |
|
Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy
|
Aug 27, 2025 |
|
Thanai Pongdee, MD - From Diagnosis to Treatment Escalation: Improving Outcomes Across the Patient Journey in Indolent Systemic Mastocytosis
|
Aug 27, 2025 |
|
Neal Shore, MD, FACS - Redefining Expectations in mHSPC: Options and Opportunities Across the Spectrum of Disease
|
Aug 20, 2025 |
|
Heinz Wiendl, MD - Neurology Updates From the European Meeting in Helsinki (June 2025)
|
Aug 20, 2025 |
|
Diana L. Bitner, MD, MSCP, FACOG - Let’s Replace Silence With Science: Patient and Provider Perspectives on Addressing the Substantial Impact of Menopausal Symptoms
|
Aug 19, 2025 |
|
Lorenza Rimassa, MD - Shifting the Paradigm in Biliary Tract Cancers: Contemporary Data and Decision-Making
|
Aug 19, 2025 |
|
Howard Trachtman, MD - Pioneering Progress In Focal Segmental Glomerulosclerosis: Time is Ticking To Save The Nephron
|
Aug 19, 2025 |
|
Saiju Jacob, MD, DPhil, FRCP, FAAN - The Value of Disease Control in gMG: The Latest Data Evaluating Patient Needs and Treatment Outcomes as They Emerge From Helsinki
|
Aug 04, 2025 |
|
Angela Kay Fitch, MD, FACP, MFOMA - Separating Signal From Noise: Overcoming the Challenges of Obesity Management in Real-World Clinical Practice
|
Aug 04, 2025 |
|
Dirk R. J. Kuypers, MD, PhD - Predicting and Achieving Long-Term Graft Survival in Solid Organ Transplant Recipients: On Track or a Challenge Too Far?
|
Aug 04, 2025 |
|
Alison Birtle, FRCP, FRCR, MD - Case Study Challenge in Advanced Bladder Cancer: Tailoring Treatment to Individual Patients
|
Jul 21, 2025 |
|
Laurent Servais, MD, PhD - Eligible for Gene Therapy? The Complexity and Therapeutic Implications of Anti-AAV Antibodies
|
Jul 21, 2025 |
|
Adam Brufsky, MD, PhD / Rebecca Dent, MD, FRCP (Canada) - Same Class, Different Agents: Practical Considerations for Managing Toxicities of Interest in Patients on TROP2-Directed Therapies in Breast Cancer
|
Jul 07, 2025 |
|
Anna Maria Geretti, MD, PhD - Understanding an Individual’s Readiness for Long-Acting Injectable Therapy
|
Jul 07, 2025 |
|
Liz Lightstone, MBBS (Hons), PhD, FRCP - Preventing Flare and Protecting Function: What Progress Is Being Made in Active Lupus Nephritis?
|
Jul 07, 2025 |
|
Marianna Fontana, MD, PhD / Julian Gillmore, MD, PhD, FRCP, FRCPath - Identifying Outcomes That Matter in ATTR-CM: Critical Considerations in the Interpretation of Contemporary Clinical Trials
|
Jun 30, 2025 |
|
Ashkan Shoamanesh, MD, FRCPC - Can We Find a New Way Forward in Secondary Stroke Prevention? Exploring the Rationale and Potential Roles for Factor XIa Inhibition
|
Jun 30, 2025 |
|
Luis Querol, MD, PhD - 2025 Congress Highlights From Edinburgh, Scotland: Breaking Down the Data Driving Novel Therapeutic Developments in CIDP
|
Jun 30, 2025 |
|
Heinz Wiendl, MD - Myasthenia Gravis Under the Microscope: 2025 Insights From The Hague
|
Jun 23, 2025 |
|
Richard David Graham Leslie, MD, FRCP, FAoP - When Could Dysglycaemia in Adults Be Type 1 Diabetes? Expert Perspectives on Recognising and Addressing Diagnostic Complexities and Challenges
|
May 30, 2025 |
|
Nicoletta Policek, PhD - When You Are Not an HIV Specialist But You Are Addressing Broader Healthcare Needs of Individuals With HIV: What Do You Need to Know?
|
May 30, 2025 |
|
Maria Dall'Era, MD - When They Need Targeted Therapy: Selecting the Optimal Treatment Approach for Lupus Nephritis in an Evolving Treatment Landscape
|
May 27, 2025 |
|
Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?
|
May 27, 2025 |
|
Chloe E. Atreya, MD, PhD / Marwan Fakih, MD - Focusing on the Patient in Front of Us: Expert Perspectives on Providing Patient-Centered Care for Refractory Metastatic Colorectal Cancer
|
May 16, 2025 |
|
Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context
|
May 16, 2025 |
|
Robert J. Motzer, MD - Advanced Renal Cell Carcinoma: Clinical Advances in Approaches to Combination Therapy
|
May 08, 2025 |
|
Bradley P. Dixon, MD, FASN / Carla M. Nester, MD, MSA, FASN - Getting to the Root of the Problem: Unlocking the Potential of Novel Complement Inhibitors in C3G and IC-MPGN
|
May 08, 2025 |
|
Nicholas J. Silvestri, MD, FAAN - From Established to Emerging Therapies: Expert Perspectives on the Latest Evidence Base on FcRn Inhibitors for gMG
|
Apr 25, 2025 |
|
Dustin A. Deming, MD - Personalizing Treatment Pathways for Refractory Metastatic Colorectal Cancer: Informed Decision-Making When Disease Has Progressed
|
Apr 21, 2025 |
|
Carla M. Nester, MD, MSA, FASN - Closing the Diagnostic Gap: Quick Fire Essentials in C3G and IC-MPGN
|
Apr 21, 2025 |
|
Diana N. Ionescu, MD - To Target We Need to Test: Why and How to Identify Folate Receptor Alpha-Positive Ovarian Cancer
|
Apr 21, 2025 |
|
Gavin Giovannoni, MBBCh, PhD - Navigating and Pioneering High-Efficacy DMT Strategies: Optimizing Patient Outcomes in Multiple Sclerosis
|
Apr 02, 2025 |
|
Enrico Lopriore, MD, PhD - Are You Managing Pregnant Individuals? Then You Need to Know About Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT)
|
Mar 26, 2025 |
|
Alessandro M. Vannucchi, MD, PhD - Not All JAKis Are Equal: What Can Trials and Real-World Evidence Tell Us About Optimal Treatment Approaches in Myelofibrosis?
|
Mar 26, 2025 |
|
James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis
|
Mar 26, 2025 |
|
Claire Harrison, DM, FRCP, FRCPath - Patient-Centred Care in Cytopenic Myelofibrosis: Collaborative Conversations on Treatment Goals and Decisions
|
Mar 05, 2025 |
|
Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls
|
Jan 13, 2025 |
|
Serdar Dalkilic, MD - Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?
|
Jan 09, 2025 |
|
Elena Pischik, MD, PhD - Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
|
Jan 09, 2025 |
|
Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria
|
Jan 03, 2025 |
|
Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient
|
Jan 02, 2025 |
|
Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)
|
Dec 27, 2024 |
|
Gregory Y. H. Lip, MD - Optimising Oral Anticoagulant Use in Atrial Fibrillation: The Role of Real-World Evidence in Informing, Individualising, and Improving Care
|
Dec 27, 2024 |
|
Ian SD Roberts, MBChB, FRCPath / Joris Roelofs, MD, PhD - Best Practices in Renal Pathology: Avoiding Common Pitfalls in the Diagnostic Pathways for Glomerular Diseases
|
Dec 17, 2024 |
|
Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy
|
Dec 17, 2024 |
|
Michael K. Wong, MD, PhD, FRCPC - When Anti-PD1 Therapy Fails: Could Oncolytic Immunotherapy Impact Outcomes in Advanced Melanoma?
|
Dec 13, 2024 |
|
Kris V. Kowdley, MD - Prioritising the Patient Experience With PBC: Are We Appreciating and Addressing the True Impact of the Disease?
|
Dec 13, 2024 |
|
Kris V. Kowdley, MD - Navigating Cases of PBC Alongside the Experts: Best Practices in Tracking Treatment Response and Targeting Contemporary Goals of Care
|
Dec 13, 2024 |
|
Erika Hamilton, MD - Safety First: Recognising and Responding to Toxicities Associated With TROP2-Directed Therapies in Metastatic Breast Cancer
|
Dec 12, 2024 |
|
Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data
|
Dec 12, 2024 |
|
Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow
|
Nov 21, 2024 |
|
John Mascarenhas, MD - Working With Our Patients as Partners in Care: Addressing Disease- and Treatment-Related Burdens Associated With Cytopenic Myelofibrosis
|
Nov 21, 2024 |
|
Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML
|
Nov 15, 2024 |
|
Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care
|
Nov 15, 2024 |
|
Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps
|
Nov 15, 2024 |
|
Richard Kim, MD - The Modern Art of Sequencing Later Lines of Treatment for Advanced Colorectal Cancer: Exploring Case Scenarios With the Experts
|
Nov 08, 2024 |
|
Carla M. Nester, MD, MSA, FASN - Novel Therapies in Focus: Updates in C3 Glomerulopathy and IC-MPGN
|
Nov 08, 2024 |
|
Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy
|
Nov 08, 2024 |
|
Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED
|
Nov 08, 2024 |
|
Karin Jordan, MD, PhD - Applying Foresight to Optimise Emesis Control in Patients Receiving Antibody-Drug Conjugates
|
Oct 25, 2024 |
|
Elena Castro, MD, PhD - Innovation and Individualisation in mHSPC and nmCRPC: Optimising Patient Outcomes and Experiences
|
Oct 25, 2024 |
|
Bruce A C Cree, MD, PhD, MAS - BTK Inhibition and Beyond: Novel Therapies in MS
|
Oct 25, 2024 |
|
Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey
|
Oct 25, 2024 |
|
Karin Jordan, MD, PhD - Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting
|
Oct 11, 2024 |
|
Peter Schmid, FRCP, MD, PhD - Staying at the Forefront of HER2 and TROP2-Directed Antibody-Drug Conjugate Advances in Breast Cancer
|
Oct 11, 2024 |
|
Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey
|
Sep 30, 2024 |
|
Jiwon Oh, MD, PhD, FRCPC - Navigating the High-Efficacy DMT Landscape in MS: Integrating New Data and Real-World Evidence
|
Sep 30, 2024 |
|
Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding
|
Sep 30, 2024 |
|
Pamela Kushner, MD, FAAFP / Magdalena Madero, MD - Taking the Updated CKD Guidelines From Paper to Practice
|
Sep 12, 2024 |
|
Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?
|
Aug 27, 2024 |
|
Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?
|
Aug 23, 2024 |
|
Jacqueline S. Garcia, MD - Small Words, Big Differences: Best Practices in Supportive Care for Patients With AML
|
Aug 22, 2024 |
|
Brandon Blue, MD - Challenging Racial Disparities in Multiple Myeloma Treatment and Outcomes: Local Solutions to Address an Endemic Problem
|
Aug 22, 2024 |
|
Richard Kim, MD - From Trial Protocol to Routine Practice: Evaluating Real-World Evidence for Later-Line Treatments in Advanced Colorectal Cancer
|
Aug 22, 2024 |
|
Philippe Moreau, MD - Assessing Current and Potential Approaches in Multiple Myeloma: Updates From Madrid 2024
|
Aug 02, 2024 |
|
Gilles Salles, MD, PhD - Differentiating Decisions in Transplant-Ineligible Relapsed/Refractory DLBCL: What Are Our Options, and How Do We Choose Between Them?
|
Aug 02, 2024 |
|
Jai Radhakrishnan, MD, MS, Getting Up to Speed in IgAN: An Expert-Led Rapid-Fire Journal Club Series
|
Aug 02, 2024 |
|
Andrea Necchi, MD - Familiar Tools, New Uses? Assessing Novel Combination Approaches in the First-Line Management of Advanced Urothelial Carcinoma
|
Jul 22, 2024 |
|
Isabel Conceição, MD - Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making
|
Jul 22, 2024 |
|
María-Victoria Mateos, MD, PhD - Updates in Multiple Myeloma From Madrid: Data Surrounding BCMA-Directed Agents and Their Clinical Relevance
|
Jul 22, 2024 |
|
Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA
|
Jul 10, 2024 |
|
Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis
|
Jul 10, 2024 |
|
Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia
|
Jul 03, 2024 |
|
Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy
|
Jul 03, 2024 |
|
Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making
|
Jun 25, 2024 |
|
Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?
|
Jun 18, 2024 |
|
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?
|
May 21, 2024 |
|
Lindsey Roeker, MD - Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents
|
May 21, 2024 |
|
Thomas Powles, MBBS, MRCP, MD - Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy
|
May 10, 2024 |
|
Sara Hurvitz, MD - A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer
|
May 10, 2024 |
|
Jeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
|
Apr 17, 2024 |
|
Dirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
|
Apr 10, 2024 |
|
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
|
Mar 28, 2024 |
|
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
|
Mar 28, 2024 |
|
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
|
Mar 26, 2024 |
|
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
|
Mar 26, 2024 |
|
Bertrand Tombal, MD, PhD - MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes
|
Mar 11, 2024 |
|
Nils Erik Gilhus, MD, PhD - Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis
|
Mar 05, 2024 |
|
Wisia Wedzicha, MD, FRCP - Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care
|
Mar 01, 2024 |
|
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
|
Feb 28, 2024 |
|
Amy E. DeZern, MD, MHS - Small Words Make Large Differences: Best Practices in Supporting MDS Patients Across All Stages of Their Journey
|
Feb 13, 2024 |
|
David M. G. Halpin, MB BS, DPhil, FERS - The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death
|
Jan 29, 2024 |
|
Ana C. Garrido-Castro, MD / Sarah L. Sammons, MD - TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct
|
Jan 25, 2024 |
|
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
|
Jan 22, 2024 |
|
Laurent Servais, MD, PhD - Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients
|
Jan 03, 2024 |
|
Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
|
Jan 03, 2024 |
|
Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting
|
Jan 03, 2024 |
|
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations
|
Dec 28, 2023 |
|
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD
|
Dec 27, 2023 |
|
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
|
Dec 21, 2023 |
|
Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations
|
Dec 21, 2023 |
|
Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment
|
Dec 19, 2023 |
|
Ronald F. van Vollenhoven, MD, PhD - Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
|
Dec 19, 2023 |
|
Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC
|
Dec 08, 2023 |
|
Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care
|
Dec 01, 2023 |
|
Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers
|
Dec 01, 2023 |
|
Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care
|
Nov 28, 2023 |
|
Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment
|
Nov 16, 2023 |
|
Sharon Walmsley, CM, MSc, MD - Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
|
Nov 10, 2023 |
|
Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools
|
Nov 10, 2023 |
|
Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?
|
Oct 30, 2023 |
|
Lorenza Rimassa, MD - When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising Treatment Planning in Cholangiocarcinoma
|
Oct 24, 2023 |
|
Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH
|
Oct 18, 2023 |
|
Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?
|
Sep 29, 2023 |
|
David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
|
Sep 29, 2023 |
|
Gilles Salles, MD, PhD - Differentiating Decisions in Transplant-Ineligible Relapsed/Refractory DLBCL: What Are Our Options, and How Do We Choose Between Them?
|
Sep 26, 2023 |
|
Antonella Castagna, MD - Designing Treatment Regimens to Suppress Multidrug-Resistant HIV: What Would You Do?
|
Sep 20, 2023 |
|
David Malka, MD, PhD - Let’s Get Personal: Effective and Individualised Management of Targeted Therapies in Cholangiocarcinoma
|
Sep 14, 2023 |
|
Jacqueline Turner, MSc - Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
|
Sep 05, 2023 |
|
Jai Radhakrishnan, MD, MS / Ladan Zand, MD - Investigating Novel Approaches and Unmet Needs in the Management of Glomerular Diseases
|
Aug 31, 2023 |
|
Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
|
Aug 23, 2023 |
|
Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HF
|
Aug 22, 2023 |
|
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
|
Aug 22, 2023 |
|
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
|
Jul 31, 2023 |
|
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
|
Jul 26, 2023 |
|
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
|
Jul 24, 2023 |
|
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
|
Jul 18, 2023 |
|
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
|
Jul 17, 2023 |
|
P. James B. Dyck, MD - When ATTR Amyloidosis Strikes a Nerve: Best Practices in Timely Suspicion, Diagnosis, and Management of ATTR-Polyneuropathy
|
Jul 17, 2023 |
|
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy
|
Jul 06, 2023 |
|
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
|
Jun 27, 2023 |
|
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
|
Jun 27, 2023 |
|
Aditya Bardia, MD, MPH - Keeping to Target in mTNBC: Optimising Outcomes With Antibody-Drug Conjugates in Practice
|
Jun 19, 2023 |
|
Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?
|
Jun 19, 2023 |
|
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
|
Jun 19, 2023 |
|
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
|
Jun 19, 2023 |
|
Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?
|
May 12, 2023 |
|
Verónica Vázquez Velázquez, PhD - Optimising Obesity Care in Adolescent Patients: Practical Blueprints to Overcome Barriers
|
May 12, 2023 |
|
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
|
May 05, 2023 |
|
Kurt G. Naber, MD, PhD - How Are We Tackling the Nemesis of Drug-Resistant Uropathogens?
|
Apr 27, 2023 |
|
Allison Agwu, MD, ScM - Me the Clinician; Me the Mom: Why Vaccinate Children Against COVID-19?
|
Apr 24, 2023 |
|
Luis Alberto Moreno, MD, PhD / Aaron Kelly, PhD - Assessing and Alleviating the Weight of Obesity in Adolescent Patients
|
Apr 19, 2023 |
|
Kevin Harrington, PhD, FRCR, FRCP - When CPS is Between 1 and 19, How Would You Manage Recurrent/Metastatic SCCHN?
|
Apr 13, 2023 |
|
Nizar Mahlaoui, MD, MPH, PhD - Simplifying Patient-Integrated Care for Those Requiring Immunoglobulin Therapy: Making Smart Moves with Automated and Digital Technology
|
Apr 13, 2023 |
|
C. Buddy Creech, MD, MPH - Children and the COVID Vaccine
|
Apr 11, 2023 |
|
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
|
Apr 11, 2023 |
|
Thomas Powles, MBBS, MRCP, MD - Education, Collaboration and Communication: Aligning Patient and Clinical Priorities in Locally Advanced and Metastatic Urothelial Carcinoma
|
Apr 04, 2023 |
|
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
|
Mar 30, 2023 |
|
Mary Frances McMullin, MD, FRCP, FRCPath - Managing Myelofibrosis: Can We Do More to Address Cytopenias, Reduce Transfusion Burden, and Improve Quality of Life?
|
Mar 29, 2023 |
|
Marina Berenguer, MD, PhD - Treating Hepatitis C Virus in Special Populations: Pregnant Women, Children and Adolescents
|
Mar 28, 2023 |
|
Andrew Ustianowski, MBBS, FRCP, PhD - Treating COVID-19 Early: What Patients Need to Know
|
Mar 28, 2023 |
|
Arndt Vogel, MD - Mobilising the Multidisciplinary Team: Collaborative Strategies to Improve Care in Early- to Intermediate-Stage HCC
|
Mar 28, 2023 |
|
Silke Gillessen, MD - Optimal Treatment of mCRPC: What Is the Place of Radioligand Therapy?
|
Mar 23, 2023 |
|
Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
|
Mar 23, 2023 |
|
Solange Peters, MD, PhD - Advancing Our Patient-Centered Approach to Care in ALK-Positive Metastatic Non-Small Cell Lung Cancer
|
Mar 23, 2023 |
|
Anil K. Gupta, MD, CCFP, FCFP - Treating COVID-19 in the Outpatient Setting: Identifying Who, With What, and When?
|
Mar 23, 2023 |
|
Amitava Banerjee, MPH, DPhil, FRCP - Long COVID and Vaccination Status: What Are We Learning?
|
Mar 23, 2023 |
|
Samuel Seidu, MD, FRCGP, FRCP (Edin) - The Power of the Primary Point of Contact: Taking Obesity From Obstacle to Opportunity
|
Mar 23, 2023 |
|
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
|
Mar 23, 2023 |
|
Andrew Ustianowski, MBBS, FRCP, PhD - What’s Right for Me: Individualising Antiretroviral Therapy in People Living With HIV
|
Mar 23, 2023 |
|
Eugen Feist, MD - Anwendung der ersten deutschen AOSD-Therapieleitlinien: die Rolle und Position von Biologika
|
Mar 23, 2023 |
|
Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy
|
Mar 23, 2023 |
|
David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis
|
Feb 17, 2023 |
|
Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team
|
Feb 14, 2023 |
|
Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?
|
Feb 03, 2023 |
|
Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More
|
Feb 03, 2023 |
|
Ronald van Vollenhoven, MD, PhD - Managing Patients with Lupus: When Should We Escalate Treatment?
|
Jan 09, 2023 |
|
Bruno Sangro, MD, PhD - A New Era in the Management of Advanced HCC: Sequencing Therapies for the Second-Line and Beyond
|
Jan 06, 2023 |
|
Frederique Penault-Llorca, MD, PhD - Setting Our Sights on Actionable Mutations in Cholangiocarcinoma: The Who, What, When, Why, and How of Testing
|
Jan 06, 2023 |
|
Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections
|
Jan 06, 2023 |
|
Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM
|
Dec 29, 2022 |
|
Susana Banerjee, MBBS, MA, PhD - When Patients With Advanced Endometrial Cancer Progress: Decisions in Treatment Initiation and Optimisation
|
Dec 28, 2022 |
|
Michael H. Hsieh, MD, PhD, FASTMH - Differentiating UTIs From STIs in Primary Care: Cases in Practice
|
Dec 28, 2022 |
|
Isabelle Ray-Coquard, MD, PhD - Turning Advanced Ovarian Cancer Into a Chronic Disease One Step at a Time
|
Dec 28, 2022 |
|
Shimu Khamlichi, BSc, ClinPsyD - Protecting the Mental Health of People Living With HIV
|
Dec 28, 2022 |
|
Jonathan Barratt, PhD, FRCP - In Pursuit of Proteinuria: Novel Therapeutic Approaches in the Management of IgAN
|
Dec 28, 2022 |
|
Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs
|
Dec 16, 2022 |
|
Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC
|
Dec 14, 2022 |
|
Graeme C Black, OBE, DPhil, FRCOphth, FMedSci - Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
|
Dec 14, 2022 |
|
Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts
|
Dec 13, 2022 |
|
Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure
|
Dec 06, 2022 |
|
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
|
Dec 05, 2022 |
|
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
|
Dec 05, 2022 |
|
Melanie J. Davies, CBE, FRCP, FMedSci - Clinical Challenges in Insulin Initiation: Overcoming Obstacles to Improved Glycaemic Control in Type 2 Diabetes
|
Dec 05, 2022 |
|
Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency
|
Nov 29, 2022 |
|
Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression
|
Nov 24, 2022 |
|
Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
|
Nov 23, 2022 |
|
Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered
|
Nov 14, 2022 |
|
Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome
|
Nov 11, 2022 |
|
José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How
|
Nov 07, 2022 |
|
"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians
"
|
Nov 07, 2022 |
|
Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat
|
Nov 01, 2022 |
|
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
|
Oct 27, 2022 |
|
Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure
|
Oct 20, 2022 |
|
Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals
|
Oct 19, 2022 |
|
Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
|
Oct 04, 2022 |
|
Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice
|
Oct 03, 2022 |
|
Ask, Spot, Refer: Identifying Acute Hepatic Porphyria in the Emergency Room
|
Sep 29, 2022 |
|
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
|
Sep 29, 2022 |
|
Hot Topics and Controversies in Adjuvant Therapy for Early-Stage, EGFR-Mutant NSCLC
|
Sep 20, 2022 |
|
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
|
Sep 20, 2022 |
|
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care
|
Sep 07, 2022 |
|
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions
|
Sep 07, 2022 |
|
Question Time: Applying New Therapies for the Management of mTNBC
|
Aug 29, 2022 |
|
New Biomarkers, New Targets in Advanced NSCLC
|
Aug 17, 2022 |
|
Managing Generalised Myasthenia Gravis: A Tale of Two Targets
|
Aug 10, 2022 |
|
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
|
Aug 01, 2022 |
|
IAP Antagonists in Oncology: What Do We Know?
|
Jul 25, 2022 |
|
Advanced Therapy for CPF in Crohn's: Evaluating the Evidence for Stem Cell Therapy and More
|
Jul 12, 2022 |
|
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
|
Jul 11, 2022 |
|
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
|
Jun 30, 2022 |
|
Lupus and the Kidney: Emerging Treatment Strategies and How to Use Them
|
Jun 07, 2022 |
|
How I Treat: Achieving Healing in CPF
|
Jun 07, 2022 |
|
Perspectives on the Management of CPF: Moving the Goalposts With Shared Decision-Making
|
Jun 07, 2022 |
|
Evolving Clinical Management of the Hospitalised COVID-19 Patient
|
May 30, 2022 |
|
The Fear of Disappearing, the Fight to Stay Present': Understanding the Needs of Patients With Alzheimer's Disease
|
May 24, 2022 |
|
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
|
May 24, 2022 |
|
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
|
May 20, 2022 |
|
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised
|
May 18, 2022 |
|
Managing Thrombosis in Cancer: A Double Debacle and Then Add COVID
|
May 18, 2022 |
|
‘B’ Vigilant: HCC Surveillance Protocols in Patients With Chronic Hepatitis B
|
May 16, 2022 |
|
Managing Complex Patients Hospitalized Due to COVID-19: Cases in Practice
|
May 16, 2022 |
|
The Patient’s Portrait When Selecting ART: Cases in Practice
|
May 16, 2022 |
|
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
|
May 06, 2022 |
|
Standards of Care in HIV: We’ve Come a Long Way, But Could We Achieve More?
|
May 05, 2022 |
|
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course
|
Apr 26, 2022 |
|
Complex Cases of Comorbidities in Patients With HCV
|
Apr 21, 2022 |
|
"De-Stigmatising Viral Hepatitis: Overcoming the Impact of the Whispered Epidemics!"
|
Apr 20, 2022 |
|
"Defining the Diagnosis and Management of Pyruvate Kinase Deficiency"
|
Apr 12, 2022 |
|
Differentiating UTIs From STIs in Primary Care: Cases in Practice
|
Apr 12, 2022 |
|
"Incorporating Immunotherapy in Advanced and Recurrent Endometrial Cancer: Applying Knowledge to Practice"
|
Mar 31, 2022 |
|
"When Hepatitis Infection Is Double Trouble: The Need for Proactive Screening for HDV"
|
Mar 31, 2022 |
|
Individualising Enzyme Replacement Therapy in Patients Living with Late-Onset Pompe Disease
|
Mar 29, 2022 |
|
When the Immune System Attacks: The Impact, Pathophysiology, and Treatment of Alopecia Areata
|
Mar 29, 2022 |
|
JAK Inhibitors in the Management of Dermatologic Disorders: Clinical Implications of the Latest Safety Findings
|
Mar 29, 2022 |
|
Shining a Light on the Treatment of Primary Hyperoxaluria 1: Does the Evidence Improve Our Options?
|
Mar 29, 2022 |
|
Mission Remission: Can This Be Achieved in the Management of Axial Spondyloarthritis?
|
Mar 29, 2022 |
|
Help, I Have COVID': Primary Care Support and Therapeutic Management of Patients With Mild/Moderate COVID-19
|
Mar 29, 2022 |
|
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
|
Mar 29, 2022 |
|
Biologics in Asthma and Nasal Polyposis: Decision-Making in Practice
|
Mar 29, 2022 |
|
Pros and Cons of Colloid Treatment: Cases in the Critically Ill
|
Mar 29, 2022 |
|
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
|
Mar 29, 2022 |
|
Optimising Outcomes for Chronic Kidney Disease: The Emerging Treatment Paradigm
|
Mar 15, 2022 |
|
Applying Revised Treatment Guidelines for Advanced Hepatocellular Carcinoma: Considerations in Real-Life Practice
|
Mar 01, 2022 |
|
The Place of Radiopharmaceuticals in an Evolving Treatment Landscape: Addressing Perceptions With Clinical Evidence to Optimise Outcomes in Men With Metastatic Prostate Cancer
|
Feb 28, 2022 |
|
"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"
|
Feb 17, 2022 |
|
"Anil K. Gupta, MD, CCFP, FCFP - Preventing COVID Progression and Transmission in the Outpatient Setting: Keeping Abreast of Therapeutic Developments"
|
Feb 17, 2022 |